The Effect of Dexpanthenol on Ototoxicity Induced by Cisplatin
1
조회
0
다운로드
1
인용
0
참고문헌
키워드
초록
Objectives. This study was aimed to investigate the protective effects of dexpanthenol (Dxp) on against cisplatin-induced ototoxicity. Methods. To examine this effect, distortion product otoacoustic emissions (DPOAEs) measurements and serum levels of oxidative and antioxidant status (including malondialdehyde, superoxide dismutase, catalase, glutathione, glutathione peroxidase, total oxidant status, total antioxidant status, and oxidative stress index) were evaluated. Thirty-two adult female Wistar albino rats were randomly divided into 4 equal groups; control (K), cisplatin (C), cisplatin plus Dxp (CD), and Dxp (D). In all groups DPOAEs measurements, between 996 and 10,078 Hz as DPOAEs and input/output functions, were performed on days 0, 1th, 5th, and 12th. Prior to death, the last DPOAEs measurements and blood samples were taken. Results. In the C group, statistically significant differences were detected at all frequencies between 0 and 5 days and 0 and 12 days measurements (P<0.05). Serum level of oxidant and antioxidant status were detected statistically significantly changed in this group versus K group (P<0.05). Contrary to the C group, in the CD group hearing ability was seen largely preserved at many frequencies and serum levels of all biochemical parameters were shifted toward normal values, similar to the K group. No significant differences were detected in the either D or K group’s measurements. Conclusion. According to these results, Dxp may prevent cisplatin-induced ototoxicity.
Abstract
Objectives. This study was aimed to investigate the protective effects of dexpanthenol (Dxp) on against cisplatin-induced ototoxicity. Methods. To examine this effect, distortion product otoacoustic emissions (DPOAEs) measurements and serum levels of oxidative and antioxidant status (including malondialdehyde, superoxide dismutase, catalase, glutathione, glutathione peroxidase, total oxidant status, total antioxidant status, and oxidative stress index) were evaluated. Thirty-two adult female Wistar albino rats were randomly divided into 4 equal groups; control (K), cisplatin (C), cisplatin plus Dxp (CD), and Dxp (D). In all groups DPOAEs measurements, between 996 and 10,078 Hz as DPOAEs and input/output functions, were performed on days 0, 1th, 5th, and 12th. Prior to death, the last DPOAEs measurements and blood samples were taken. Results. In the C group, statistically significant differences were detected at all frequencies between 0 and 5 days and 0 and 12 days measurements (P<0.05). Serum level of oxidant and antioxidant status were detected statistically significantly changed in this group versus K group (P<0.05). Contrary to the C group, in the CD group hearing ability was seen largely preserved at many frequencies and serum levels of all biochemical parameters were shifted toward normal values, similar to the K group. No significant differences were detected in the either D or K group’s measurements. Conclusion. According to these results, Dxp may prevent cisplatin-induced ototoxicity.
참고문헌 (30)
- Williams CJ., "Cis-platinum : a new anticancer agent", Br Med J, 1(6179), pp.1689~1691 (1979)
- Rabik CA., "Molecular mechanisms of resistance and toxicity associated with platinating agents", Cancer Treat Rev, 33(1), pp.9~23 (2007)
- Rossof AH., "Preliminary clinical experience with cis-diamminedichloroplatinum(II)(NSC 119875, CACP)", Cancer, 30(6), pp.1451~1456 (1972)
- JEFF KOPELMAN, "OTOTOXICITY OF HIGH-DOSE CISPLATIN BY BOLUS ADMINISTRATION IN PATIENTS WITH ADVANCED CANCERS AND NORMAL HEARING", The Laryngoscope, 98(8), pp.858~864 (1988), Wiley-Blackwell[DOI]
- Kalcioglu MT., "The protective effect of erdosteine against ototoxicity induced by cisplatin in rats", Eur Arch Otorhinolaryngol, 262(10), pp.856~863 (2005)
- Lopez-Gonzalez MA., "Ototoxicity caused by cisplatin is ameliorated by melatonin and other antioxidants", J Pineal Res, 28(2), pp.73~80 (2000)
- Kathleen C.M. Campbell, "d-Methionine provides excellent protection from cisplatin ototoxicity in the rat", Hearing Research, 102(1-2), pp.90~98 (1996), Elsevier BV[DOI]
- Campbell KC., "The effect of D-methionine on cochlear oxidative state with and without cisplatin administration : mechanisms of otoprotection", J Am Acad Audiol, 14(3), pp.144~156 (2003)
- Ebner F., "Topical use of dexpanthenol in skin disorders", Am J Clin Dermatol, 3(6), pp.427~433 (2002)
- Slyshenkov VS., "Pantothenic acid protects jurkat cells against ultraviolet light-induced apoptosis", Free Radic Biol Med, 30(11), pp.1303~1310 (2001)
- Slyshenkov VS., "Pantothenic acid and its derivatives protect Ehrlich ascites tumor cells against lipid peroxidation", Free Radic Biol Med, 19(6), pp.767~772 (1995)
- Ermis H., "Protective effect of dexpanthenol on bleomycin-induced pulmonary fibrosis in rats", Naunyn Schmiedebergs Arch Pharmacol, 386(12), pp.1103~1110 (2013)
- Mihara M., "Determination of malonaldehyde precursor in tissues by thiobarbituric acid test", Anal Biochem, 86(1), pp.271~278 (1978)
- Sun Y., "A simple method for clinical assay of superoxide dismutase", Clin Chem, 34(3), pp.497~500 (1988)
- Aebi H., "Methods of enzymatic analysis", pp.673~677 (1974), Academic Press
- Paglia DE., "Studies on the quantitative and qualitative characterization of erythrocyte glutathione peroxidase", J Lab Clin Med, 70(1), pp.158~169 (1967)
- Ellman GL, "Tissue sulfhydryl groups", Arch Biochem Biophys, 82(1), pp.70~77 (1959)
- Erel O, "A novel automated direct measurement method for total antioxidant capacity using a new generation, more stable ABTS radical cation", Clin Biochem, 37(4), pp.277~285 (2004)
- Erel O, "A new automated colorimetric method for measuring total oxidant status", Clin Biochem, 38(12), pp.1103~1111 (2005)
- Aycicek A., "Decreased total antioxidant capacity and increased oxidative stress in passive smoker infants and their mothers", Pediatr Int, 47(6), pp.635~639 (2005)
- Sagit M., "Protective effect of thymoquinone against cisplatin-induced ototoxicity", Eur Arch Otorhinolaryngol, 270(8), pp.2231~2237 (2013)
- Thomas C. Kelly, "Aminoguanidine reduces cisplatin ototoxicity", Hearing Research, 186(1-2), pp.10~16 (2003), Elsevier BV[DOI]
- Tina Huang, "Oxidative stress-induced apoptosis of cochlear sensory cells: otoprotective strategies", International Journal of Developmental Neuroscience, 18(2-3), pp.259~270 (2000), Elsevier BV[DOI]
- Yumusakhuylu AC., "Protective role of resveratrol against cisplatin induced ototoxicity in guinea pigs", Int J Pediatr Otorhinolaryngol, 76(3), pp.404~408 (2012)
- Ozturan O., "Monitoring of cisplatin ototoxicity by distortion-product otoacoustic emissions", Auris Nasus Larynx, 23, pp.147~151 (1996)
- Ichikawa I., "Renal antioxidant enzymes : their regulation and function", Kidney Int, 45(1), pp.1~9 (1994)
- Kizilay A., "Caffeic acid phenethyl ester ameliorated ototoxicity induced by cisplatin in rats", J Chemother, 16(4), pp.381~387 (2004)
- Iraz M., "Aminoguanidine prevents ototoxicity induced by cisplatin in rats", Ann Clin Lab Sci, 35(3), pp.329~335 (2005)
- Lech Wojtczak, "Protection by pantothenic acid against apoptosis and cell damage by oxygen free radicals - The role of glutathione", BioFactors, 17(1-4), pp.61~73 (2003), Wiley-Blackwell[DOI]
- Vyacheslav S. Slyshenkov, "Pantothenic acid and pantothenol increase biosynthesis of glutathione by boosting cell energetics", FEBS Letters, 569(1-3), pp.169~172 (2004), Wiley-Blackwell[DOI]